China SXT Pharmaceuticals Inc (SXTC) — Working Capital to Net Assets Ratio
China SXT Pharmaceuticals Inc (SXTC) has a Working Capital to Net Assets ratio of 99.2% as of September 2025. Working capital of $20.08 Million (current assets of $26.04 Million minus current liabilities of $5.96 Million) is measured against net assets of $20.23 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of China SXT Pharmaceuticals Inc to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
China SXT Pharmaceuticals Inc Working Capital to Net Assets (2016–2025)
This chart shows how China SXT Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of September 2025, the ratio stands at 99.2%, reflecting working capital of $20.08 Million against net assets of $20.23 Million USD. Check China SXT Pharmaceuticals Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for China SXT Pharmaceuticals Inc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for China SXT Pharmaceuticals Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see China SXT Pharmaceuticals Inc (SXTC) total market value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.0% | $15.28 Million | $15.44 Million | $21.30 Million | $6.01 Million | ▲ +60.7 pp |
| 2024 | 38.3% | $5.33 Million | $13.93 Million | $14.23 Million | $8.90 Million | ▲ +4.1 pp |
| 2023 | 34.2% | $5.02 Million | $14.69 Million | $19.52 Million | $14.50 Million | ▲ +1.7 pp |
| 2022 | 32.5% | $5.33 Million | $16.42 Million | $22.45 Million | $17.12 Million | ▲ +3.3 pp |
| 2021 | 29.2% | $4.65 Million | $15.96 Million | $23.23 Million | $18.58 Million | ▼ -49.3 pp |
| 2020 | 78.4% | $7.37 Million | $9.40 Million | $19.64 Million | $12.26 Million | ▼ -5.0 pp |
| 2019 | 83.4% | $9.27 Million | $11.11 Million | $15.59 Million | $6.32 Million | ▲ +30.8 pp |
| 2018 | 52.7% | $1.73 Million | $3.29 Million | $6.10 Million | $4.37 Million | ▼ -18.9 pp |
| 2017 | 71.6% | $1.33 Million | $1.85 Million | $4.91 Million | $3.58 Million | ▲ +47.3 pp |
| 2016 | 24.3% | $180.22K | $742.77K | $5.73 Million | $5.55 Million | — |